Westwood, MA, United States of America

Joey L Methot

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.9

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Joey L Methot

Introduction

Joey L Methot is a notable inventor based in Westwood, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Joey L Methot holds a patent for RIPK1 inhibitors and methods of use. The patent describes compounds of Formula I or a pharmaceutically acceptable salt thereof. These compounds act as RIPK1 inhibitors and can be useful in preventing, treating, or acting as a remedial agent for RIPK1-related diseases. This innovation showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Methot is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the field. His work has led to advancements in therapeutic options for patients suffering from various conditions.

Collaborations

Throughout his career, Joey has worked alongside talented colleagues such as Phieng Siliphaivanh and Brandon A Vara. These collaborations have fostered an environment of innovation and creativity, contributing to the success of their projects.

Conclusion

Joey L Methot's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to pave the way for new treatments and therapies that can benefit many patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…